Based on the values of beta coefficients, we can state that according to the SF-36, the main negative predictors of quality of life are: 1) DM treatment 2) pain intensity 3) age 4) wound etiology and 5) use of wheelchair. Results: Of the patients who participated in this study, 68% were men and 32% women, their average age was 65 years, and the length of DM treatment was 19 years, with variations in DM treatment, UADF intensity, etiology, and size and degree of UADF, according to Wagner classification. The model was realized using the ENTER method. Exploratory Regression analysis was used during the study as a descriptive technique. The data were acquired using the SF-36 and Wound-QoL questionnaires. Methods: A cross-sectional study was conducted on 167 patients with UADF.
VERMA, SUBODH DHINGRA, NITISH K BUTLER, JAVED ANKER, STEFAN D FERREIRA, JOAO PEDRO FILIPPATOS, GERASIMOS JANUZZI, JAMES L LAM, CAROLYN S P SATTAR, NAVEED PEIL, BARBARA NORDABY, MATIAS BRUECKMANN, MARTINA POCOCK, STUART J ZANNAD, FAIEZ PACKER, MILTON PACKER, M ANKER, S BUTLER, J FILIPPATOS, G POCOCK, S ZANNAD, F FERREIRA, JP BRUECKMANN, M GEORGE, J JAMAL, W, et al.Aim: To ascertain quality of life in patients with ulcer affected diabetic foot (UADF), and to establish whether there was a relationship between respondentsʼ gender, age, duration and type of treatment for DM, duration of treatment for and etiology of wound, intensity of pain, degree of UADF, method of off-loading pressure on the foot, and quality of life. Effect of Early Treatment with Ivermectin among Patients with Covid-19. RUTON, HINDA SPRAGUE, SHEILA MCKAY, PAULA GUO, CHRISTINA M. OLIVEIRA, ROSEMARY HARARI, OFIR FORREST, JAMIE I. Reis, Gilmar Reis, Gilmar SILVA, EDUARDO A.S.M. Evaluating COVID-19 vaccines in the real world. Fluvoxamine for the treatment of COVID-19 - Author's reply. AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, v.
#FARSKY BATA SIZE TRIAL#
Resilient Clinical Trial Infrastructure in Response to the COVID-19 Pandemic: Lessons Learned from the TOGETHER Randomized Platform Clinical Trial. SPRAGUE, SHEILA MCKAY, PAULA Reis, Gilmar MILLS, EDWARD J. RAWAT, ANGELI DUAILIBE, FELIPE GUO, CHRISTINA M. Seção coletada automaticamente pelo EscavadorįORREST, JAMIE I. Pesquisador atuante nas seguintes linhas de pesquisa: Coronariopatias Adquiridas, Determinação de Biomarcadores na Saúde e no Ambiente e Estudo epidemiológico dos agravos crônicos de saúde e doenças endêmicas em populações Coordenador do Curso de Medicina da PUC Minas campus Contagem. FELLOW of the American College of Cardiology FELLOW of the European Society of Cardiology.
PROFESSOR ADJUNTO-IV, Departamento de Medicina, Instituto de Ciências Biológicas e da Saúde da Universidade Católica de Minas Gerais desde 2.003. Livre-Docente Edimar Alcides Bocchi em 2.001. DOUTOR em Cardiologia pelo Instituto do Coração (InCor) da FMUSP, São Paulo, SP sob a orientação do Prof. RESEARCH FELLOW e MESTRE em Cardiologia pela University of Michigan, Ann Arbor MI, USA sob a orientação do Prof. ESPECIALISTA em Cardiologia pela Sociedade Brasileira de Cardiologia, RJ, em 1992.
RESIDÊNCIA médica em Medicina interna no Hospital Semper em Belo Horizonte 1989/1990, RESIDÊNCIA médica em Cardiologia no Hospital Vera Cruz em Belo Horizonte, MG, 1991/ 1992. MÉDICO formado Universidade Federal de Minas Gerais em Belo Horizonte, MG, 1989.
0 kommentar(er)
